Buprenorphine vs Trastuzumab
Buprenorphine vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Buprenorphine and Trastuzumab.
Mechanism of Action
Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Buprenorphine — 24-42 hours; Trastuzumab — 28 days.
Chemical Properties
Molecular Formula: Buprenorphine — C29H41NO4.
Molecular Weight: Buprenorphine — 467.6430 g/mol.
Type: Buprenorphine — Small molecule; Trastuzumab — Antibody.